Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer (PANTELO)

Institut Cancerologie de l'Ouest

Status: Unknown

Conditions: Pancreatic Cancer Metastatic; Adenocarcinoma; Pain

Treatments: Other: Telemedicine

Study type: Interventional

Funder types: Other

Identifiers

NCT04667403

ICO-2020-13

Details and patient eligibility

About

Adenocarcinoma of the pancreas is a major public health issue because of its disastrous prognosis. The symptomatology of locally advanced or metastatic forms, particularly painful, is often major and difficult to balance, impacting both the quality of life of patients (and those around them) and the course of treatment (chemotherapy).

The objective of this study is to evaluate the interest and feasibility of telemedicine in the management of pain in patients undergoing treatment for advanced or metastatic pancreatic cancer.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient ≥ 18 years old ;
• Patient with histologically or cytologically proven locally advanced and/or metastatic adenocarcinoma of the pancreas;
• Patient undergoing or failing medical treatment and comfort care only;
• Patient with EVA ≥ 4 and/or requiring analgesics level 3;
• Performans Status (ECOG) < 3 ;
• Informing the patient and obtaining free, informed and written consent signed by the patient and the investigator;
• Patient affiliated or beneficiary of the social security system

Exclusion criteria

• Patient does not have a smartphone, tablet or computer;
• Patient with no personal internet access at home (WIFI, wired), or via his smartphone;
• Patient does not feel able to fill out an electronic questionnaire;
• Patient cannot read or write French;
• Patient does not speak and understand French;
• Persons deprived of liberty or under guardianship or trusteeship ;
• Dementia, mental alteration or psychiatric pathology that could compromise the patient's informed consent and/or compliance with the protocol and follow-up of the trial ;
• Inability to submit to trial protocol follow-up for geographical, social, or other reasons ;
• Patient participating in another interventional study evaluating treatment and pain management.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Telemedicine

Experimental group

Description:

Pain is monitored, from the patient's home, using a computer application accessible from a smartphone or a computer with internet access. This application will allow the patient to describe his or her pain by means of a self-questionnaire. Healthcare professionals (nurse coordinator, pain specialist and oncologist) will thus be able to remotely interpret the data collected, enabling them to provide patients with a rapid response to adapt their pain treatment without the patient having to travel to the establishment.

Treatment:

Other: Telemedicine